Characterized to selectively mimic the phenotype associated with CDK12 loss of function using Recursion’s AI-powered maps of human biology.

CEO Christopher Gibson was one of those sellers, with a Thursday reveal that he had sold 40,390 shares of Recursion's common ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a clinical-stage biotechnology company integrating artificial intelligence ...

In TODAY.com's Expert Tip of the Day, a psychologist reveals a simple strategy to set boundaries during conversations with a ...

This neuroscience-backed method will help you pinpoint the exact cause of your procrastination so you can finally beat it.

Quick thinking has its place in the classroom, but students who also master slower, more deliberate thinking develop the skills to know when each approach serves them best.